Journal of Antimicrobial Chemotherapy · 1980 · 85 citations · 0 references
MedicineMicrobiologyPharmacologyChemotherapyMedical MicrobiologyMycologyAntifungal AgentsAntifungal PharmacologyAntifungal PharmacotherapyAntifungal ResistanceAntifungal TherapyAntifungal AntibioticsAntifungal ChemotherapyAntimicrobial ChemotherapyNew Antifungal AgentsNovel Antifungal Drug Development
Ketoconazole, a new water-soluble synthetic imidazole derivative which is absorbed into the bloodstream after oral administration, was inhibitory in vitro to a range of pathogenic yeasts and fungi in concentrations from 0.1 to 64 mg/L The drug was effective in vivo in the treatment of experimental dermatophytosis in guinea pigs and experimental systemic candidosis in rabbits. It is considered to be of potential value in the treatment of human mycoses.